- Home
- HITI vs BDTX Comparison
HITI vs BDTX Comparison
Compare HITI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- BDTX
- Stock Information
- Founded
- HITI 2009
- BDTX 2014
- Country
- HITI Canada
- BDTX United States
- Employees
- HITI N/A
- BDTX N/A
- Industry
- HITI
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HITI
- BDTX Health Care
- Exchange
- HITI Nasdaq
- BDTX Nasdaq
- Market Cap
- HITI 257.8M
- BDTX 220.3M
- IPO Year
- HITI N/A
- BDTX 2020
- Fundamental
- Price
- HITI $2.67
- BDTX $3.79
- Analyst Decision
- HITI Strong Buy
- BDTX Strong Buy
- Analyst Count
- HITI 2
- BDTX 6
- Target Price
- HITI $6.13
- BDTX $10.17
- AVG Volume (30 Days)
- HITI 450.1K
- BDTX 1.1M
- Earning Date
- HITI 09-15-2025
- BDTX 11-06-2025
- Dividend Yield
- HITI N/A
- BDTX N/A
- EPS Growth
- HITI N/A
- BDTX N/A
- EPS
- HITI N/A
- BDTX 0.38
- Revenue
- HITI $410,600,094.00
- BDTX $70,000,000.00
- Revenue This Year
- HITI $14.07
- BDTX N/A
- Revenue Next Year
- HITI $29.67
- BDTX N/A
- P/E Ratio
- HITI N/A
- BDTX $10.00
- Revenue Growth
- HITI 11.18
- BDTX N/A
- 52 Week Low
- HITI $1.64
- BDTX $1.20
- 52 Week High
- HITI $4.06
- BDTX $4.94
- Technical
- Relative Strength Index (RSI)
- HITI 38.02
- BDTX 44.99
- Support Level
- HITI $2.47
- BDTX $3.67
- Resistance Level
- HITI $2.74
- BDTX $3.96
- Average True Range (ATR)
- HITI 0.12
- BDTX 0.29
- MACD
- HITI -0.01
- BDTX -0.06
- Stochastic Oscillator
- HITI 32.50
- BDTX 7.84
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.